Ambio Life Sciences has published Ibogaine and the Bicameral Mind, a book by CEO and co-founder Jonathan Dickinson covering ibogaine’s pharmacology, history and clinical use.

The book was released on 8 September 2026 by Inner Traditions/Park Street Press. It presents ibogaine’s proposed “bicameral state” and examines its potential neuroregenerative applications for mild traumatic brain injury, Parkinson’s disease and other neurodegenerative conditions.